SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC
http://www.w3.org/2000/01/rdf-schema#comment
"MiR-29a mimics decrease the levels of Tet1 Tet2 and Tet3; miR-29a inhibition increases all three Tets in human dermal fibroblasts."
xsd:string
http://purl.uniprot.org/uniprot/#_4BF9027F393A26C0644609479DDDC1F6B636A20230C0F18869CE1FCE5EBD7C98684008E5E1A720F960B604AD428B9E05
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC
http://purl.uniprot.org/uniprot/Q6N021
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC
http://purl.uniprot.org/uniprot/#_Q6N021-mappedCitation-23820384
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7B31801236AC2FE7DD1F0B4BAF54497B85BC3C211A0C81A8337F7710AA92E44752B1E7E8336CF6DB5F33D4E9C48D8BEC